Cingulate Inc.·4

Jul 20, 7:29 PM ET

Hargroves Thomas Jeffrey 4

4 · Cingulate Inc. · Filed Jul 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Cingulate Director Thomas Hargroves Receives 20,000-Share Option Award

What Happened
Thomas Jeffrey Hargroves, a director of Cingulate Inc. (CING), received a grant of 20,000 derivative shares (an option award) on 2026-07-16. The filing shows an acquisition price of $0.00 (no immediate cash paid). This was an award/grant (derivative), not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-07-16; Form 4 filed: 2026-07-20 (filed within the two-business-day reporting window).
  • Transaction type/code: A (award/grant), derivative securities.
  • Shares granted: 20,000; acquisition price reported: $0.00 (no cash outlay at grant).
  • Shares owned after transaction: not specified in the provided filing.
  • Footnote: The option vests on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of Cingulate’s 2027 annual meeting of stockholders.
  • No indication in the filing of an immediate sale or cashless exercise.

Context: This is a compensation-style option grant to a director that vests over time; such awards are common for board service and do not represent an open-market buy or sell. Because it’s a derivative award with a vesting condition, it does not immediately increase transferable common shares until the options vest and are exercised.

Insider Transaction Report

Form 4
Period: 2026-07-16
Transactions
  • Award

    Stock Option (right to Buy)

    [F1]
    2026-07-16+20,00020,000 total
    Exercise: $4.43Exp: 2036-07-16Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The option vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Cingulate Inc. 2027 annual meeting of stockholders.
Signature
/s/ Shane J. Schaffer, Attorney-in-Fact|2026-07-20

Documents

1 file
  • 4
    ownership.xmlPrimary

    4